Male hypogonadism (testosterone deficiency; primary & secondary)
gonadal · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Deficient testosterone +/- impaired spermatogenesis. Primary (testicular, high LH/FSH): Klinefelter, orchitis, trauma, chemo/radiation, cryptorchidism. Secondary (hypothalamic-pituitary, low/normal LH/FSH): pituitary tumour/hyperprolactinaemia, obesity/metabolic, opioids/steroids, haemochromatosis, systemic illness, congenital (Kallmann). Diagnosis needs symptoms PLUS repeatedly low morning testosterone.
Red flags
- Secondary hypogonadism with headache/visual field defect — pituitary macroadenoma, urgent imaging
- Very low testosterone + raised ferritin/transferrin saturation — haemochromatosis
- Priapism, high haematocrit (>0.54), rising PSA on treatment
- Gynaecomastia + small firm testes (Klinefelter) — karyotype
Assessment
Differential diagnosis
- Primary (hypergonadotrophic) vs secondary (hypogonadotrophic) hypogonadism — LH/FSH distinguishes
- Functional suppression: obesity, opioids, glucocorticoids, anabolic steroid abuse, acute illness, OSA
- Hyperprolactinaemia / pituitary macroadenoma
- Haemochromatosis (gonadotrophin failure + iron overload)
- Normal ageing with low SHBG (calculate free testosterone)
- Depression, hypothyroidism, chronic disease
Investigations
- Fasting morning (08:00-11:00) total testosterone on ≥2 occasions (circadian + day-to-day variation)
- LH and FSH (high = primary/testicular; low/inappropriately normal = secondary/central)
- SHBG + calculated free testosterone if total is borderline or SHBG altered (obesity, ageing)
- Prolactin (exclude prolactinoma), ferritin/transferrin saturation (haemochromatosis), TSH, HbA1c
- If secondary: pituitary MRI and full anterior pituitary screen (esp. if very low T, visual symptoms, headache)
- Semen analysis if fertility desired; karyotype if primary and small firm testes (Klinefelter)
- Baseline PSA, haematocrit before considering testosterone therapy
Management
- Confirm with symptoms + repeated low morning testosterone before labelling/treating
- Identify and reverse functional causes first (weight loss, stop/reduce opioids & exogenous androgens, treat OSA)
- Classify primary vs secondary with LH/FSH; image pituitary and exclude prolactinoma/haemochromatosis in secondary
- If fertility desired and secondary cause: use gonadotrophins (hCG +/- FSH) or pulsatile GnRH — NOT testosterone (suppresses sperm)
- If replacement indicated and fertility not an issue: start testosterone, choose formulation by preference
- Baseline then monitor testosterone, haematocrit, PSA, symptoms at 3-6 months then annually
- Counsel: testosterone is contraindicated with active prostate/breast cancer, high Hct, untreated severe OSA, desire for near-term fertility
Drugs & doses
Testosterone gel 50 mg (transdermal) once daily, titrate to mid-normal level; wash hands, avoid skin transfer to women/children
Testosterone undecanoate 1000 mg IM every 10-14 weeks (long-acting depot) [verify local scheduling]
Testosterone enanthate/cypionate 100-200 mg IM every 2-3 weeks (shorter-acting)
hCG 1500-2000 IU SC twice weekly (+/- FSH) for fertility in secondary hypogonadism — not testosterone
Treat hyperprolactinaemia cause with dopamine agonist (cabergoline) if prolactinoma is the driver
Disposition
Outpatient endocrine/andrology/fertility. Urgent pituitary referral if macroadenoma/visual symptoms. Not an ED condition unless complication (priapism, pituitary apoplexy).
Complications & pitfalls
- Osteoporosis, reduced muscle mass, infertility
- On therapy: polycythaemia, worsening OSA, acne, suppressed spermatogenesis, oedema
- Unmasking/accelerating occult prostate cancer (monitor PSA)
- Cardiovascular considerations in older men (individualise)
Exam pearls
- Diagnose only with BOTH symptoms and repeatedly low morning testosterone — a single low level is not enough.
- Obesity, opioids and exogenous anabolic steroids are common reversible causes — address these before lifelong replacement.
- If a man wants fertility, do NOT give testosterone (it suppresses the HPG axis and sperm) — use hCG/gonadotrophins.
- Always exclude prolactinoma and haemochromatosis in secondary (hypogonadotrophic) hypogonadism.
- Check haematocrit and PSA at baseline and on follow-up during testosterone therapy.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.